MYOS RENS Technology Inc (MYOS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

45 HORSEHILL ROAD CEDAR KNOLLS, NJ 07927

MYOS RENS Technology Inc. operates as a biopharmaceutical company. The Company discovers, develops, and commercializes therapeutics and nutritional products that improves muscle health and function essential to the management of sarcopenia, cachexia, and chronic and acute muscle diseases. MYOS RENS Technology serves the healthcare sector in the United States.

Data based on most recent fiscal year report
Market Cap13.77 Million Shares Outstanding9.18 Million Avg Volume37.949 Thousand
1-Yr BETA vs S&P TR0.361 Current Ratio1.78 Quick Ratio0.75
View SEC Filings from MYOS instead.

View recent insider trading info

Funds Holding MYOS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MYOS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

1.1 Million total shares from 5 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MATLIN DAVID J

  • Director
  • 10% Owner
0 2020-04-01 1

PECHOCK CHRISTOPHER

  • Director
343,802 2020-03-05 1

MANNELLO JOSEPH CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,371,028 2020-03-05 1

DEWEY CHRISTOPHER C

  • Director
322,371 2020-03-05 2

PONTE ANDREW JOEL

  • Director
94,193 2020-03-05 2

EINHORN ANDREW J. CHIEF FINANCIAL OFFICER

  • Officer
118,517 2020-01-28 0

LEVINE JACK

  • Director
0 2019-12-12 0

DIAMANDIS PETER

  • Director
0 2019-11-19 0

HARIRI ROBERT J

  • Director
0 2019-05-02 0

ARONNE LOUIS J.

  • Director
50,953 2019-02-06 0

MANDEL VICTOR E

  • Director
79,055 2019-02-06 0

NOSTA JOHN

  • Director
32,274 2019-02-06 0

ZALTAS ERIC

  • Director
0 2018-12-13 0

LYU ZHENGGUANG

  • Director
122,228 2016-12-28 0

SRIVASTAVA SAPNA CHIEF FINANCIAL & STATEGY OFFR

  • Officer
159,031 2016-05-05 0

REN REN

  • Director
  • 10% Owner
1,518,182 2016-04-11 0

REN REN

RENS TECHNOLOGY INC

RENS AGRICULTURE SCIENCE & TECHNOLOGY CO, LTD

  • Director
  • 10% Owner
1,500,000 2016-03-03 0

ZHOU BIN

  • Director
0 2016-03-03 0

ZHAO GUIYING

  • Director
0 2016-03-03 0

TOUSSAINT KENRICK BRYCE CHIEF EXECUTIVE OFFICER

  • Officer
10,000 2015-12-24 0

DOSSANTOS JOSEPH INTERIM PRESIDENT AND CFO

  • Officer
5,000 2015-11-06 0

LEVY PETER PRESIDENT AND COO

  • Officer
0 2015-01-12 0

ALDRIN BUZZ

  • Director
0 2015-01-12 0

ASHTON ROBERT C. JR. CHIEF MEDICAL OFFICER

  • Officer
0 2015-01-12 0

VENTER JOHN CRAIG

  • Director
0 2015-01-12 0

DEFREITAS CARL CHIEF FINANCIAL OFFICER

  • Officer
0 2014-02-18 0

FLEISCHER GLEN R.

  • FORMER CEO
No longer subject to file 2013-04-25 0

DIVENUTO JANINE

  • 10% Owner
7,755,000 2011-09-30 0

BERNSTEIN JEFFREY L. CEO AND PRESIDENT

  • Officer
  • Director
0 2011-02-25 0

COLKER CARLON M CHIEF MED OFF AND EXEC VP

  • Officer
  • 10% Owner
7,024,000 2011-02-25 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MATLIN DAVID J - > 10% Owner

2020-03-06 P 206,611 $1.21 a 1,267,477 1,267,477.00 direct

MANNELLO JOSEPH - Director - Officer CHIEF EXECUTIVE OFFICER

2020-03-05 P 681,818 $1.21 a 1,371,028 1,371,028.00 direct

DEWEY CHRISTOPHER C - Director

2020-03-05 P 82,645 $1.21 a 322,371 322,371.00 direct

PECHOCK CHRISTOPHER - Director

2020-03-05 P 82,645 $1.21 a 339,802 343,802.00 direct

PONTE ANDREW JOEL - Director

2020-03-05 P 82,645 $1.21 a 94,193 94,193.00 direct

Elevate your investments